Edward Mullins PhD, MRCOG

Dr. Edward Mullins is a Clinical Lecturer at Imperial College, London, and the George Institute for Global Health and Locum Consultant in Obstetrics and Gynaecology at Queen Charlotte’s and Chelsea Hospital, London.

His Ph.D. at Imperial College investigated the fetal and maternal inflammatory response in Fetal Growth Restriction. Following this, Ed won a fellowship with Professor Dame Sally Davies, England CMO, as editor-in-chief of the CMO’s annual report, ‘Women: the health of the 51%.’ As an NIHR Academic Clinical Lecturer, Ed has investigated self-monitoring of maternal cardiovascular health and the prevention of Gestational Diabetes.

During the COVID-19 pandemic, Ed was seconded as clinical adviser to Professor Chris Whitty, England CMO, and produced rapid reviews on coronavirus infection in pregnancy and in children, which he presented to SAGE and formed the basis of clinical guidelines for the UK.

He is co-CI for PAN-COVID, an NIHR-funded global registry of women affected by suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates. Ed is also co-CI for the COM-SARS-2 study, a historical seroprevalence study in 11,000 maternal serum samples to evaluate the introduction and onset of community transmission of SARs-CoV-2 in NW London.

Ed has led a new clinical service to introduce post-birth contraception for all women in NW London, to allow women to access reliable family planning before discharge from their maternity service. He hopes to evaluate this and support the national roll-out.